The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

EDITORIAL

DAPT: a historical accident in the pharmacological treatment of post-percutaneous coronary intervention

EuroIntervention 2016;11:1449-1450. DOI: 10.4244/EIJV11I13A281

1. Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Cardiovascular Science Division of the NHLI, Imperial College of Science, Technology and Medicine, London, United Kingdom


In 1977, when Andreas Gruentzig was treating his first patient, he was of course confronted with the basic question of which treatment should be administered post-vessel injury. Whom did he consult to resolve the problem? It was said at the time that he consulted the rising star in the field of atherothrombosis, a young Spanish cardiologist who had just emigrated to the United States, Valentin Fuster. Only Valentin himself can confirm whether this story is true or not, whether Andreas consulted him or not, but the fact is that Andreas used aspirin in his patients to control the thrombotic process ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Bioresorbable scaffolds for the treatment of in-stent restenosis: an alternative to double metal layers?